Compliance with the PMCPA Code may help to avoid violations of the UK Bribery Act 2010 *

United Kingdom - July 19 2011
The Association of the British Pharmaceutical Industry (ABPI), the UK Prescription Medicines Code of Practice Authority (PMCPA), and the UK Serious Fraud Office (SFO) have reached a memorandum of understanding (MoU) relating to aspects of the application of the UK Bribery Act 2010 (Act) to the pharmaceutical industry.

Co-authors: Maarten Meulenbelt, Maurits J.F. Lugard, Dorothy Cory-Wright.

---

UK Bribery Act implementation – what businesses should be doing *

United Kingdom - April 6 2011
On 1 July 2011 the Bribery Act 2010 (the "Act") will come into force.

Co-authors: Steven Pitt, Dorothy Cory-Wright, John Bedford.

---

Finally – new anti-bribery legislation for the UK *

United Kingdom - April 14 2010
New anti-bribery legislation received Royal Assent on 8 April 2010 just before parliamentary business was finalised in advance of the election.

Co-authors: Dorothy Cory-Wright.

---

BAE Systems plc agrees to pay substantial fines in the U.S. and UK to resolve bribery charges *

USA - March 3 2010
2010 is on pace to be a record-setting year for enforcement of the Foreign Corrupt Practices Act ("FCPA"), as evidenced by the recent announcement of another major enforcement action.

Co-authors: Dorothy Cory-Wright, Paul V. Gerlach, Joseph B. Tompkins Jr., Karen A. Popp, Leslie A. Shubert.

---

UK “life sciences blueprint” stresses innovation, signals shift in cost-effectiveness policy *

United Kingdom - August 10 2009
The recently released UK "Life Sciences Blueprint" (the Blueprint), which provides an important roadmap for future government investment in, and regulation of, the pharmaceutical and biotechnology industries, signals a significant shift in cost-effectiveness requirements for pharmaceutical, biologic, and device manufacturers.

Co-authors: William Sarraille, Maurits J.F. Lugard, James C. Stansel, Peter McKenzie Currie.

---